We are live on ! Find out more
AST.WS

Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017)
AST.WS

Delisted

AST.WS was delisted on the 26th of September, 2017.

Back to rankings

35 hedge funds and large institutions have $362K invested in Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 2

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

3% less funds holding

Funds holding: 36 → 35 (-1)

11% less capital invested

Capital invested by funds: $406K → $362K (-$44K)

Holders
35
Holders Change
-1
Holders Change %
-2.78%
% of All Funds
0.87%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
6
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CL
CSS LLC
Illinois
+$39.9K
2
BlackRock
BlackRock
New York
+$1.05K
3
UBS Group
UBS Group
Switzerland
+$162
4
Morgan Stanley
Morgan Stanley
New York
+$112
5
AG
Advisor Group
Arizona
+$10

Top Sellers

Rank Fund Capital Flow
1
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS)
California
-$2K
2
Bank of America
Bank of America
North Carolina
-$1
3
Northern Trust
Northern Trust
Illinois
-$1
Name Holding Trade Value Shares
Change 		Change in
Stake
BC
1
Broadwood Capital
New York
$140K – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$73K – – –
CL
3
CSS LLC
Illinois
$46K +$39.9K +108,542 New
Vanguard Group
4
Vanguard Group
Pennsylvania
$39K – – –
MHP
5
Manatuck Hill Partners
Connecticut
$32K – – –
BCM
6
Bridgeway Capital Management
Texas
$13K – – –
Goldman Sachs
7
Goldman Sachs
New York
$9K – – –
Northern Trust
8
Northern Trust
Illinois
$7K -$1 -4 -0%
AIG
9
American International Group
New York
$1K – – –
New York State Common Retirement Fund
10
New York State Common Retirement Fund
New York
$1K – +1 +0.1%
BlackRock
11
BlackRock
New York
$1K +$1.05K +2,856 New
California State Teachers Retirement System (CalSTRS)
12
California State Teachers Retirement System (CalSTRS)
California
– -$2K -4,423 Closed
Bank of America
13
Bank of America
North Carolina
– -$1 -2 -1%
Creative Planning
14
Creative Planning
Kansas
– +$1 +3 +2%
LTFS
15
Ladenburg Thalmann Financial Services
Florida
– +$3 +8 +6%
AG
16
Advisor Group
Arizona
– +$10 +27 +90%
Morgan Stanley
17
Morgan Stanley
New York
– +$112 +304 +23%
UBS Group
18
UBS Group
Switzerland
– +$162 +442 +54%

AST.WS Hedge Fund Activity: Q1 2017 in Review

35 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) (AST.WS) for Q1 2017, worth a combined $362K — down 11% from $406K a quarter earlier.

Fund positioning in AST.WS was balanced in Q1 2017: 3 funds opened new positions, 3 closed out, 6 added to existing stakes and 2 trimmed.

The largest buyer was CSS LLC, opening a new position worth an estimated $39.9K. The largest seller was California State Teachers Retirement System (CalSTRS), exiting entirely with an estimated $2K sold.

  • 35 institutional investors held Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) (AST.WS) as of Q1 2017, down from 36 in Q4 2016.
  • Funds reported $362K of Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) stock for Q1 2017, down 11% quarter-over-quarter.
  • 3 funds opened new Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) positions in Q1 2017 and 3 closed out, a net change of 0 holders.
  • The largest Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) buyer in Q1 2017 was CSS LLC, an estimated $39.9K added.
  • The largest Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) seller in Q1 2017 was California State Teachers Retirement System (CalSTRS), an estimated $2K sold.

Based on aggregated 13F filings for Q1 2017.